3Rs principles put into practice: animals and alternatives

Join us for an insightful two-part webinar, featuring expert perspectives on advancing ethical and scientific standards in animal research. In Part 1 - “**Animal Models, 3R Principles, and Alternative In Vitro Models**,” **Giuliano Grignaschi**, Head of the Animal Welfare Office at the University of Milan, will explore the implementation of the 3Rs—Replacement, Reduction, and Refinement—in compliance with European Directive 63/2010. He will discuss the ongoing necessity of using live animals in certain scientific procedures while emphasizing the importance of systematically applying the 3Rs throughout the entire research process. This session will highlight strategies to ensure high standards of animal welfare, including prioritizing alternative methods such as invertebrates and non-animal techniques whenever feasible. In Part 2 - "**How Can We Best Design Pharmacological Experiments to Produce Reliable Data While Complying with the 3Rs**” - **Fabrizio Gardoni**, Professor of Pharmacology at the University of Milan, will address the challenges of designing robust pharmacological experiments that align with the 3Rs principles. His presentation will cover best practices for optimizing experimental design through power analysis, employing innovative alternatives like in vitro models and organ-on-chip systems, and enhancing reproducibility via standardized protocols and open data sharing. Additionally, he will discuss refinement approaches that minimize animal suffering and the integration of cutting-edge technologies—including artificial intelligence and machine learning—to improve data reliability while upholding ethical responsibility. Together, these complementary presentations provide a comprehensive overview of how the 3Rs can be effectively incorporated into scientific research, balancing the pursuit of knowledge with the highest standards of animal welfare. Don’t miss this opportunity to deepen your understanding of ethical research practices and innovative alternatives in the life sciences Animal models, 3R principles, and alternative in vitro models In agreement with the European Directive 63/2010 on the protection of animals used for scientific purposes, “while it is desirable to replace the use of live animals in procedures by other methods not entailing the use of live animals, the use of live animals continues to be necessary to protect human and animal health and the environment”. However, until full replacement of live animals in scientific and educational procedures is achieved, it is fundamental to ensure a high level of protection for animals that still need to be used in procedures. To ensure that the way in which animals are bred, cared for and used in procedures complies with international and national standards, the principles of the 3Rs (Replacement, Reduction and Refinement) should be considered systematically through a strict hierarchy of the requirement to use alternative methods. Replacement refers to the preferred use of invertebrates, with the sole exception of cephalopods that are included in the scope of the EU Directive (partial Replacement), or non-animal methods (total Replacement) over animal methods whenever it is possible to achieve the same scientific aim. This seminar will discuss how the 3Rs should be implemented from project conception to completion and beyond. How can we best design pharmacological experiments to produce reliable data while complying with the 3Rs Designing robust experiments in pharmacology that yield reliable data while adhering to the principles of the 3Rs (Replacement, Reduction, and Refinement) is a critical challenge in preclinical research. Achieving this balance requires a multifaceted approach that integrates rigorous experimental design, advanced statistical methods, and ethical considerations. Key strategies include the use of power analysis to determine optimal sample sizes, minimizing animal use without compromising statistical validity. Employing in vitro models, organ-on-chip systems, and computational simulations can serve as effective alternatives to animal studies, supporting the Replacement principle. Moreover, standardizing protocols and enhancing transparency through open data sharing can reduce variability and improve reproducibility. Refinement can be achieved by implementing non-invasive techniques, improving animal welfare conditions, and utilizing endpoints that reduce suffering. Integrating these approaches with modern technologies, such as artificial intelligence for data analysis and machine learning for predictive modeling, can further enhance the reliability of pharmacological data while respecting ethical standards. This webinar will discuss best practices for designing experiments in pharmacology, focusing on the interplay between scientific rigor and ethical responsibility.